Systemic Sclerosis-Associated Interstitial Lung Disease: Real Cases, Real Conundrums, Real Clinical Solutions

TARGET AUDIENCE:
This activity was developed for a national audience of pulmonologists, radiologists, rheumatologists, dermatologists, and primary care physicians, and other clinicians who have a role in the diagnosis and treatment of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
PROGRAM OVERVIEW:
Four cases are discussed in this activity by Flavia Castelino, MD, and Sonye Danoff, MD, PhD, that provide clinical insights into the risks of lung involvement, latest advances in guidelines and research, diagnostic testing, disease progression assessment, and shared decision-making. Join Drs. Castelino and Danoff for this active learning activity on the diagnosis and treatment of patients with SSc-ILD.
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be better able to:
• Explain the risk for and symptoms suggestive of lung involvement in patients with scleroderma
• Discuss the latest advances in clinical guidelines and research related to systemic sclerosis-associated interstitial lung disease (SSc-ILD)
• Engage best practices in the diagnostic testing and disease-progression assessment of SSc-ILD
• Employ shared decision-making strategies to optimize health outcomes in patients with SSc-ILD, including in patients with associated comorbidities